Eagle Health Investments’s Eli Lilly LLY Stock Holding History

Eagle Health Investments’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Buy	+1,994	New	+$2.04M	0.4%	24

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Eagle Health Investments's LLY Position: Q2 2026 in Review

Eagle Health Investments opened a new position in Eli Lilly (LLY) in Q2 2026: 1,994 shares worth $2.39M. The stake represents 0.4% of the portfolio and ranks #24 among its holdings.

3,194 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Eagle Health Investments held 1,994 shares of Eli Lilly worth $2.39M as of Q2 2026.
Eli Lilly was a new Eagle Health Investments position in Q2 2026.
Eli Lilly made up 0.4% of Eagle Health Investments's portfolio in Q2 2026, its #24 holding.
3,194 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Eagle Health Investments's 13F filing for Q2 2026, filed 10 Aug 2026.